Competitor Analysis: Biologic and Immune Therapy of S. aureus InfectionsLa Merie PublishingMarch 1, 2010 28 Pages - SKU: LAM2610343 |
|
Outsourcing in Drug Discovery: The Contract Research Organization (CRO) Market, 5th Edition
5/11/2012 | published by: Kalorama Information
The drug discovery process is long, arduous and costly, which has driven outsourcing in this field. The first phase is discovery of a lead compound, a molecule that affects biological function by binding to a
|
more...
|
$3,995.00
|
|
Retinal Vein Occlusion Therapeutics - Pipeline Assessment and Market Forecasts to 2019
5/21/2012 | published by: GlobalData
Retinal Vein Occlusion Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Summary GlobalData, the industry analysis specialist, has released its new report, “Retinal Vein Occlusion Therapeutics - Pipeline Assessment and Market Forecasts to 2019”. The report
|
more...
|
$3,995.00
|
|
Point of Care Diagnostics Bundle (POC Diagnostic Markets, POC Diagnostics for Emerging Infectious Diseases, POC Dx in Physician Office Labs)
3/2/2012 | published by: Kalorama Information
Point of Care Diagnostics represents one of the highest-growth industries in testing. This bundle allows Kalorama Information customers to save by purchasing one PDF which contains our most popular previously published reports on point-of-care
|
more...
|
$3,995.00
|
|
Hemorrhoids Global Clinical Trials Review, H1, 2012
4/25/2012 | published by: GlobalData
Hemorrhoids Global Clinical Trials Review, H1, 2012 Summary GlobalData's clinical trial report, “Hemorrhoids Global Clinical Trials Review, H1, 2012 provides data on the Hemorrhoids clinical trial scenario. This report provides elemental information and data relating to the
|
more...
|
$1,000.00
|
|
Hepatic Encephalopathy Global Clinical Trials Review, H1, 2012
4/25/2012 | published by: GlobalData
Hepatic Encephalopathy Global Clinical Trials Review, H1, 2012 Summary GlobalData's clinical trial report, “Hepatic Encephalopathy Global Clinical Trials Review, H1, 2012 provides data on the Hepatic Encephalopathy clinical trial scenario. This report provides elemental information and data
|
more...
|
$1,000.00
|
|
Hepatic Injury Global Clinical Trials Review, H1, 2012
4/25/2012 | published by: GlobalData
Hepatic Injury Global Clinical Trials Review, H1, 2012 Summary GlobalData's clinical trial report, “Hepatic Injury Global Clinical Trials Review, H1, 2012 provides data on the Hepatic Injury clinical trial scenario. This report provides elemental information and data
|
more...
|
$1,000.00
|
|
Hepatic Insufficiency Global Clinical Trials Review, H1, 2012
4/25/2012 | published by: GlobalData
Hepatic Insufficiency Global Clinical Trials Review, H1, 2012 Summary GlobalData's clinical trial report, “Hepatic Insufficiency Global Clinical Trials Review, H1, 2012 provides data on the Hepatic Insufficiency clinical trial scenario. This report provides elemental information and data
|
more...
|
$1,000.00
|
|
Lung Injury Global Clinical Trials Review, H1, 2012
4/25/2012 | published by: GlobalData
Lung Injury Global Clinical Trials Review, H1, 2012 Summary GlobalData's clinical trial report, “Lung Injury Global Clinical Trials Review, H1, 2012 provides data on the Lung Injury clinical trial scenario. This report provides elemental information and data
|
more...
|
$1,000.00
|
|
Pulmonary Arterial Hypertension – Pipeline Review, H1 2012
4/19/2012 | published by: Global Markets Direct
Pulmonary Arterial Hypertension – Pipeline Review, H1 2012 Summary Global Markets Direct’s, 'Pulmonary Arterial Hypertension - Pipeline Review, H1 2012', provides an overview of the Pulmonary Arterial Hypertension therapeutic pipeline. This report provides information on the therapeutic
|
more...
|
$500.00
|
|
2012 Global Infectious Disease Testing Market Outlook: Growth Opportunities and Strategies
4/20/2012 | published by: Venture Planning Group
The infectious disease testing market is one of the most rapidly growing segments of the in vitro diagnostics industry, and the greatest challenge facing suppliers in the 21st century. Among the main driving forces
|
more...
|
$28,700.00
|
Related Markets
Infectious Diseases Reports
- Antibacterials Market to 2017 - Innovative Anti-Infectives that Target MDR Gram-Negative Pathogens Offer Significant Revenue Potential
- Global Infectious Disease Treatment Market 2011-2014
- World Market for Anti-Infectives: Antifungals, Antibacterials and Antivirals (Treatments for HIV, HBV, HCV, Urinary Tract, Respiratory, Candidiasis and Other Infections)
- Global Infectious Disease Market Outlook: Facilities, Test Volume, and Sales Forecasts by Country
- Influenza Vaccine Market Opportunities and Challenges: Worldwide Forecast

